Drug
Immunofluorescence Imaging
Immunofluorescence Imaging is a pharmaceutical drug with 4 clinical trials. Currently 2 active trials ongoing. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 2 completed trials
Completion Rate
100%(2/2)
Active Trials
2(50%)
Results Posted
50%(1 trials)
Phase Distribution
No phase data available
Trial Status & Enrollment
Completion Rate
100.0%
2 of 2 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
2
trials recruiting
Total Trials
4
all time
Status Distribution
Active(2)
Completed(2)
Detailed Status
Completed2
Recruiting1
Active, not recruiting1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
2
Success Rate
100.0%
Trials by Status
completed250%
recruiting125%
active_not_recruiting125%
Recent Activity
2 active trials
Showing 4 of 4
recruiting
Study of ICG Fluorescence Imaging in Open Fracture and Infection Patients
NCT06793644
completed
ICG Fluorescence Imaging in Post-traumatic Infection
NCT04403204
active_not_recruiting
ICG Fluorescence Imaging in Open Fracture Trauma Patients
NCT04416412
completed
ICG Fluorescence Imaging in Trauma Patients
NCT04245111
Clinical Trials (4)
Showing 4 of 4 trials
NCT06793644
Study of ICG Fluorescence Imaging in Open Fracture and Infection Patients
NCT04403204
ICG Fluorescence Imaging in Post-traumatic Infection
NCT04416412
ICG Fluorescence Imaging in Open Fracture Trauma Patients
NCT04245111
ICG Fluorescence Imaging in Trauma Patients
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4